Future Care for Medical Industries (FCMI) results, Q4 2023
Net profit, assets, equity and cash flow for Q4 2023, against the same period a year earlier, from the published financial statements.
Net profit1.24 millionEGP · −16.3% vs the same period a year earlier
Total assets104 millionEGP · +60.0% vs the same period a year earlier
Shareholders' equity61.07 millionEGP · +0.6% vs the same period a year earlier
Operating cash flow23.05 millionEGP · +342.4% vs the same period a year earlier
In short
- Future Care for Medical Industries (FCMI)'s net profit for Q4 2023 was about 1.24 million EGP, down −16.3% from 1.49 million EGP in Q4 2022.
- Total assets at the end of Q4 2023 were about 104 million EGP, and shareholders' equity about 61.07 million EGP.
- Operating cash flow for Q4 2023 was positive at 23.05 million EGP.
Key lines against the same period a year earlier
This periodQ4 2022Change
Net profit1.24 million1.49 million−16.3%
Gross profit8.39 million2.78 million+201.7%
Total assets104 million64.99 million+60.0%
Total liabilities42.94 million4.3 million+897.5%
Shareholders' equity61.07 million60.68 million+0.6%
Total liabilities and equity104 million64.99 million+60.0%
Operating cash flow23.05 million-9.51 million+342.4%
Investing cash flow-2.77 million-10.5 thousand−26295.2%
Financing cash flow-19.49 million-327 thousand−5867.2%
Net change in cash785 thousand-9.85 million+108.0%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Future Care for Medical Industries (FCMI)'s Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy